Drugs / LCAR-C182A cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03890198 | Apr 2019 → Mar 2020 | gastric cancer, pancreatic ductal adenocarcinoma | First Affiliated Hospital Xi'an Jiaotong University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LCAR-C182A cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03890198 ↗ |
| Modality | Cell therapy | “an Anti-Claudin18.2 CAR-T Cell Therapy” NCT03890198 ↗ |